Waygo weight loss injection — what the research and UK regulators say

What SURMOUNT-1 and STEP 1 actually demonstrated about licensed injections

The two large phase-3 programmes that underpinned UK licensing tell a clear story. SURMOUNT-1, published in the New England Journal of Medicine and cited by NICE in its December 2024 appraisal of tirzepatide, randomised 2,539 adults with obesity over 72 weeks. At the 15mg maintenance dose, participants lost an average of around 20–21% of body weight. That's a figure from a tightly controlled trial alongside a reduced-calorie diet and increased physical activity, not a stand-alone outcome you'd replicate by taking an injection alone. The STEP 1 trial, also published in the NEJM, ran 68 weeks with semaglutide 2.4mg and found an average reduction of around 15%. Both trials required participants to meet clear eligibility criteria. Both medicines are now licensed by the MHRA and reviewed by NICE. That regulatory pathway (clinical trial data, independent expert scrutiny, prescriber assessment) is what separates these medicines from anything sold under an unverified brand name like "Waygo."

Why "Waygo" injection searches are a safety signal worth taking seriously

If you're reading this after finding "Waygo" on social media or an unfamiliar website, you're probably feeling a mixture of hope and scepticism. That second instinct is the useful one. The MHRA has issued multiple public warnings about fake weight-loss pens sold online, including counterfeit products that looked like genuine licensed medicines but contained different substances entirely. In one enforcement sweep in 2025, around 20 million doses of illegally traded weight-loss medicines with an estimated street value of around £45 million were seized. A first illicit UK manufacturing site producing counterfeit tirzepatide pens was raided in Northampton the same year. Any seller offering a weight-loss injection without requiring a prescription from a registered prescriber is operating outside UK law. Red flags include unfamiliar brand names, prices well below the market range for licensed medicines, and no verifiable pharmacy registration. You can check any online pharmacy instantly on the GPhC pharmacy register, if it isn't there, don't buy from it.

Which licensed injection might suit you, and what eligibility looks like

Both Mounjaro and Wegovy are licensed for adults with a BMI of 30 or above, or a BMI of 27 or above alongside at least one weight-related condition such as high blood pressure, type 2 diabetes, high cholesterol, or obstructive sleep apnoea. Lower BMI thresholds apply for some ethnic backgrounds under UK guidance. The prescriber also considers your full medical history: existing conditions, current medicines, and anything that might affect safety. If you have seen references to the wag weight loss injection and want to understand what a legitimate version of that treatment actually involves, our dedicated page walks through the clinical detail. Tirzepatide is started at 2.5mg (a dose chosen for tolerability rather than effect) and is titrated gradually. Semaglutide follows a similar step-up approach, and if you have come across references to the weight loss injection r, our page explains what that medicine is, how it compares, and who it suits. For a factual breakdown of how costs compare across providers, the weight loss injection prices page is a useful reference point before you commit to anything. Neither medicine is suitable during pregnancy, while breastfeeding, or if you're actively trying to conceive; treatment is also not licensed for anyone under 18. A prescriber works through all of this with you before anything is issued. That process isn't a formality, it's what makes the treatment safe. The NHS tirzepatide information page gives a plain-English overview of how the medicine works, common side effects, and when to get urgent help.

Accessing a licensed weight loss injection through a regulated UK pharmacy

The legal route to either medicine is a prescription following clinical assessment by a registered prescriber. Through a regulated online weight loss injection service, that process can be straightforward: a consultation, identity and weight verification, and a review by a GPhC-registered Independent Prescriber. A real clinician reads your answers, not software. At nume, every consultation is personally reviewed the same day by one of our prescribers; you can read more about our clinical team on the prescriber profile page. Orders placed before 12pm Monday to Friday and approved that day are dispatched the same day and arrive with DPD the next working day, in plain packaging. If you have questions about whether a particular option, such as the m injection for weight loss, could be appropriate for your circumstances, our team can talk you through the differences during your consultation. Our frequently asked questions cover eligibility, the consultation process, and what happens after your first pen. When you're ready to find out whether treatment is right for you, check your eligibility through a free consultation, there's no charge to speak to our team.